Order Article Reprints

Karapetyan L, Gooding W, Li A, Yang X, Knight A, Abushukair HM, Vargas De Stefano D, Sander C, Karunamurthy A, Panelli M, et al. Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma. Cancers. 2022; 14(20):4973. https://doi.org/10.3390/cancers14204973

Karapetyan, Lilit, William Gooding, Aofei Li, Xi Yang, Andrew Knight, Hassan M. Abushukair, Danielle Vargas De Stefano, Cindy Sander, Arivarasan Karunamurthy, Monica Panelli, and et al. 2022. "Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma" Cancers 14, no. 20: 4973. https://doi.org/10.3390/cancers14204973

Karapetyan, L., Gooding, W., Li, A., Yang, X., Knight, A., Abushukair, H. M., Vargas De Stefano, D., Sander, C., Karunamurthy, A., Panelli, M., Storkus, W. J., Tarhini, A. A., & Kirkwood, J. M. (2022). Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma. Cancers, 14(20), 4973. https://doi.org/10.3390/cancers14204973